<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Mon, 20 Apr 2026 21:01:42 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/mithilsoodmoneymantra/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Aurobindo gets final USFDA approval for gReyataz]]></title><description><![CDATA[This is a limited competition drug with two generics in the market, expect Aurobindo to gain good market share in this drug.]]></description><link>http://direct.ecency.com/mithilsoodmoneymantra/@jainlove/aurobindo-gets-final-usfda-approval-for-greyataz</link><guid isPermaLink="true">http://direct.ecency.com/mithilsoodmoneymantra/@jainlove/aurobindo-gets-final-usfda-approval-for-greyataz</guid><category><![CDATA[mithilsoodmoneymantra]]></category><dc:creator><![CDATA[jainlove]]></dc:creator><pubDate>Tue, 26 Jun 2018 18:22:18 GMT</pubDate></item></channel></rss>